Key Highlights
- On March 31, 2026, ARK Invest acquired approximately $240 million in OpenAI Group shares distributed across three exchange-traded funds
- The AI company simultaneously completed a historic $122 billion capital raise, establishing an $852 billion company valuation
- Additional ARK investments included expanded positions in CoreWeave and DoorDash
- The firm liquidated more than 600,000 Strata Critical Medical shares and reduced holdings in Veracyte and Teradyne
- This transaction marks the first opportunity for everyday investors to gain exposure to a private entity through ARK’s publicly available funds
Cathie Wood’s investment management firm, ARK Invest, executed one of its most substantial single-session transactions on March 31, 2026, acquiring approximately $240 million in OpenAI Group equity across three separate exchange-traded funds.
The investment was distributed among the ARK Innovation ETF, the ARK Next Generation Internet ETF, and the ARK Blockchain and Fintech Innovation ETF. Each of these funds currently maintains approximately a 3% ownership position in OpenAI Group PBC, Series C.
Prior to this transaction, OpenAI shares were exclusively held within ARK’s closed-end Venture Fund. That particular fund initiated its OpenAI position during 2024 and subsequently deployed an additional $250 million investment in October of the same year.
ARK’s strategic acquisition coincided with a significant capital announcement from OpenAI. That same day, the artificial intelligence company finalized its most substantial funding round to date, raising $122 billion and elevating its market valuation to $852 billion.
According to OpenAI, the newly raised capital will be allocated toward semiconductor procurement, data center infrastructure, and talent acquisition. Additionally, the company facilitated approximately $3 billion in direct share sales to individual investors through a private placement coordinated by three prominent financial institutions.
OpenAI’s Chief Financial Officer, Sarah Friar, emphasized the company’s commitment to providing retail investors access not merely to its technological innovations, but also to the potential financial returns associated with the company’s growth.
Implications of OpenAI ETF Integration for Everyday Investors
By incorporating OpenAI shares into publicly traded exchange-traded funds, ARK is establishing an unprecedented avenue for retail investors to obtain exposure to a privately held enterprise. This approach represents a departure from typical investment structures, as most individual investors lack access to private company equity before initial public offerings.
However, this opportunity comes with certain considerations. While ETFs maintain continuous trading throughout market hours, private company valuations lack real-time price discovery. Asset managers must utilize valuation estimates for these holdings and may need to liquidate more liquid securities to accommodate investor withdrawal requests.
Cathie Wood addressed the strategic move, noting that within the fintech ecosystem, agentic artificial intelligence will generate remarkable investment opportunities.
Additional ARK Portfolio Adjustments on March 31
In addition to the OpenAI acquisition, ARK purchased 26,515 shares of CoreWeave, a cloud computing infrastructure provider, representing approximately $2.05 million. CoreWeave’s stock appreciated 12% during that trading session.
ARK simultaneously added 14,729 DoorDash shares valued at $2.21 million. This transaction followed a previous DoorDash acquisition the prior day, expanding ARK’s exposure to the on-demand food delivery industry.
Regarding portfolio reductions, ARK divested 612,483 shares of Strata Critical Medical, generating $2.56 million in proceeds. The healthcare logistics company specializes in urgent medical services for US healthcare institutions.
ARK additionally sold 6,204 Teradyne shares for $1.84 million and disposed of 115,718 Veracyte shares across its ARKK and ARKG ETFs, totaling $3.52 million. The firm had been systematically decreasing its Veracyte allocation throughout the preceding week.
The OpenAI capital raise concluded with the $852 billion valuation on March 31, 2026, coinciding precisely with ARK’s $240 million deployment across its three principal exchange-traded funds.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
